Quantification of liver fat with respiratory-gated quantitative chemical shift encoded MRI

Journal of Magnetic Resonance Imaging

Volumn 42, Issue 5, 2015, Pages 1241-1248

  Motosugi, Utaroh ^a,b   Hernando, Diego ^a   Bannas, Peter ^a,c   Holmes, James H ^d   Wang, Kang ^d   Shimakawa, Ann ^d   Iwadate, Yuji ^e   Taviani, Valentina ^f   Rehm, Jennifer L ^g   Reeder, Scott B ^a,g,h  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d GE HEALTHCARE   (United States)

^e GE HEALTHCARE   (United Kingdom)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^h UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

fat quantification; liver; magnetic resonance imaging; navigator echo; respiratory monitoring

Indexed keywords

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FATTY LIVER; FEASIBILITY STUDY; FEMALE; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; LIPID ANALYSIS; LIVER FAT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON DENSITY FAT FRACTION; RESPIRATORY GATED QUANTITATIVE CHEMICAL SHIFT ENCODED MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; LIVER; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY;

PROTON;

FATTY LIVER; FEMALE; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTONS; REPRODUCIBILITY OF RESULTS;

EID: 84945478904     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24896     Document Type: Article

References (31)

1. Angulo P, Keach JC, Batts KP, Lindor KD,. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-1362.
2. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR,. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474.
3. Kleiner DE, Brunt EM, Van Natta M, et al., Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
4. Bedossa P, Dargere D, Paradis V,. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457.
5. Ratziu V, Charlotte F, Heurtier A, et al., Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-1906.
6. Mishra P, Younossi ZM,. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gastroenterol 2007; 102: 2716-2717.
7. Kodama Y, Ng CS, Wu TT, et al., Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007; 188: 1307-1312.
8. Artz NS, Hines CD, Brunner ST, et al., Quantification of hepatic steatosis with dual-energy computed tomography: comparison with tissue reference standards and quantitative magnetic resonance imaging in the ob/ob mouse. Invest Radiol 2012; 47: 603-610.
9. Reeder SB, Cruite I, Hamilton G, Sirlin CB,. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011; 34: 729-749.
10. Reeder SB, Hu HH, Sirlin CB,. Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging 2012; 36: 1011-1014.
11. Yokoo T, Bydder M, Hamilton G, et al., Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 2009; 251: 67-76.
12. Reeder SB,. Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis. Hepatology 2013; 58: 1877-1880.
13. Hernando D, Kramer JH, Reeder SB,. Multipeak fat-corrected complex R2∗ relaxometry: theory, optimization, and clinical validation. Magn Reson Med 2013; 70: 1319-1331.
14. Dongiovanni P, Fracanzani AL, Fargion S, Valenti L,. Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. J Hepatol 2011; 55: 920-932.
15. Kew MC,. Hepatic iron overload and hepatocellular carcinoma. Liver Cancer 2014; 3: 31-40.
16. Marks B, Mitchell DG, Simelaro JP,. Breath-holding in healthy and pulmonary-compromised populations: effects of hyperventilation and oxygen inspiration. J Magn Reson Imaging 1997; 7: 595-597.
17. Gay SB, Sistrom CL, Holder CA, Suratt PM,. Breath-holding capability of adults. Implications for spiral computed tomography, fast-acquisition magnetic resonance imaging, and angiography. Invest Radiol 1994; 29: 848-851.
18. Asbach P, Warmuth C, Stemmer A, et al., High spatial resolution T1-weighted MR imaging of liver and biliary tract during uptake phase of a hepatocyte-specific contrast medium. Invest Radiol 2008; 43: 809-815.
19. Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB,. Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med 2007; 58: 354-364.
20. Brau AC, Beatty PJ, Skare S, Bammer R,. Comparison of reconstruction accuracy and efficiency among autocalibrating data-driven parallel imaging methods. Magn Reson Med 2008; 59: 382-395.
21. Yu H, McKenzie CA, Shimakawa A, et al., Multiecho reconstruction for simultaneous water-fat decomposition and T2∗ estimation. J Magn Reson Imaging 2007; 26: 1153-1161.
22. Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB,. Multiecho water-fat separation and simultaneous R2∗ estimation with multifrequency fat spectrum modeling. Magn Reson Med 2008; 60: 1122-1134.
23. Yu H, Shimakawa A, Hines CD, et al., Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction. Magn Reson Med 2011; 66: 199-206.
24. Hernando D, Artz NS, Hamilton G, Roldan-Alzate A, Reeder S,. Fully automated processing of multi-echo spectroscopy data for liver fat quantification. In: Proc 22th Annual Meeting ISMRM, Milan; 2014 (abstract 2884).
25. Szczepaniak LS, Nurenberg P, Leonard D, et al., Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462-468.
26. Chandarana H, Block TK, Rosenkrantz AB, et al., Free-breathing radial 3D fat-suppressed T1-weighted gradient echo sequence: a viable alternative for contrast-enhanced liver imaging in patients unable to suspend respiration. Invest Radiol 2011; 46: 648-653.
27. Reiner CS, Neville AM, Nazeer HK, et al., Contrast-enhanced free-breathing 3D T1-weighted gradient-echo sequence for hepatobiliary MRI in patients with breath-holding difficulties. Eur Radiol 2013; 23: 3087-3093.
28. Chandarana H, Block KT, Winfeld MJ, et al., Free-breathing contrast-enhanced T1-weighted gradient-echo imaging with radial k-space sampling for paediatric abdominopelvic MRI. Eur Radiol 2014; 24: 320-326.
29. Azevedo RM, de Campos RO, Ramalho M, Heredia V, Dale BM, Semelka RC,. Free-breathing 3D T1-weighted gradient-echo sequence with radial data sampling in abdominal MRI: preliminary observations. AJR Am J Roentgenol 2011; 197: 650-657.
30. Kuhn JP, Hernando D, Mensel B, et al., Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. J Magn Reson Imaging 2014; 39: 1494-1501.
31. Yokoo T, Shiehmorteza M, Hamilton G, et al., Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 2011; 258: 749-759.